Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
https://www.zacks.com/stock/news/2242107/are-investors-undervaluing-collegium-pharmaceutical-coll-right-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_2-2242107
Mar 18, 2024 - Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
0
Here's Why You Should Invest in Aldeyra (ALDX) Stock Now
https://www.zacks.com/stock/news/2236651/here-s-why-you-should-invest-in-aldeyra-aldx-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2236651
Mar 06, 2024 - Here, we discuss some reasons why investing in Aldeyra Therapeutics (ALDX) stock now may turn out to be a prudent move.
0
Are You Looking for a Top Momentum Pick? Why Collegium Pharmaceutical (COLL) is a Great Choice
https://www.zacks.com/stock/news/2234845/are-you-looking-for-a-top-momentum-pick-why-collegium-pharmaceutical-coll-is-a-great-choice?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_10-2234845
Mar 01, 2024 - Does Collegium Pharmaceutical (COLL) have what it takes to be a top stock pick for momentum investors? Let's find out.
0